<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2005-9-1-69-74</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-796</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>ФАРМАКОЛОГИЧЕСКАЯ КОРРЕКЦИЯ ОКСИДАТИВНОГО СТРЕССА, ИНДУЦИРОВАННОГО ДОКСОРУБИЦИНОМ, В ПОЧКАХ КРЫС</article-title><trans-title-group xml:lang="en"><trans-title>PHARMACOLOGICAL CORRECTION OF DOXORUBICIN-INDUCED OXIDATIVE STRESS IN KIDNEYS OF RATS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саенко</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Saenko</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра фармакологии и кафедра терапии и профессиональных болезней, медицинский факультет</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Напалкова</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Napalkova</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра фармакологии и кафедра терапии и профессиональных болезней, медицинский факультет</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шутов</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Shutov</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра фармакологии и кафедра терапии и профессиональных болезней, медицинский факультет</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брынских</surname><given-names>Г. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Brynskikh</surname><given-names>G. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра фармакологии и кафедра терапии и профессиональных болезней, медицинский факультет</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Ульяновский государственный университет</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>10</day><month>01</month><year>2005</year></pub-date><volume>9</volume><issue>1</issue><fpage>69</fpage><lpage>74</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Саенко Ю.В., Напалкова С.М., Шутов А.М., Брынских Г.Т., 2005</copyright-statement><copyright-year>2005</copyright-year><copyright-holder xml:lang="ru">Саенко Ю.В., Напалкова С.М., Шутов А.М., Брынских Г.Т.</copyright-holder><copyright-holder xml:lang="en">Saenko Y.V., Napalkova S.M., Shutov A.M., Brynskikh G.T.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/796">https://journal.nephrolog.ru/jour/article/view/796</self-uri><abstract><p>ЦЕЛЬ ИССЛЕДОВАНИЯ. Доксорубицин (ДОК) – антрациклиновый антибиотик с широким спектром противоопухолевой активности. Использование ДОК сдерживается кардио и нефротоксичностью препарата, которая реализуется, в том числе, через индукцию оксидативного стресса. Целью исследования явилось определение возможности фармакологи ческой коррекции оксидативного стресса, вызванного доксорубицином, в почках крыс. МАТЕРИАЛ И МЕТОДЫ. Исследование выполнено на 35 самцах беспородных белых крыс. Животные были разделены на 5 групп: контрольная группа (контроль, n=7), группа, в которой животным внутрибрюшинно водился доксорубицин из расчета 7,5 мг/кг массы (ДОК, n=7); группа, в которой животным перед инъекцией ДОК внутривенно вводили гормон эпифиза мелатонин в дозе 1 мг/кг (МЕЛ, n = 7), группа, в которой животным перед инъекцией ДОК внутривенно вводили аминокислоту глицин в дозе 50 мг/ кг (глицин, n = 7), группа, в которой животным перед инъекцией ДОК внутривенно вводили унитиол в дозе 5 мг/кг (унитиол, n = 7). Забой животных проводили через 24 часа путем декапитации. В гомогенате ткани почки исследовали содержание восстановленного глутатиона (ГSH), активность глютатион-трансферазы (ГSТ), активность цитоплазматической НАД(Ф)Н: хинон оксидоредуктазы 1 (НХО1), активность глутатион редуктазы (ГР), содержание белковых карбонильных групп. РЕЗУЛЬТАТЫ. Введение доксорубицина приводило к снижению уровня ГSH и активности ГР. Разницы в содержании белковых карбонильных групп не отмечено. Предварительное введение мелатонина и глицина приводило к нормализации ГSH, активности ГР и увеличению активности НХО 1 в ткани почек. ЗАКЛЮЧЕНИЕ. Гормон эпифиза мелатонин и аминокислота глицин ослабляют проявления оксидативного стресса, индуцированного доксорубицином, в почках крыс.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM of the investigation was Doxorubicin (DOX) as a widely used anthracycline antibiotic. Administration of DOX is limited due to cardio and renal toxicity because of oxidative stress. Our aim was to investigate early nephrotoxic effects of a single dose of DOX and impact of pretreatment with melatonin, glycine and unithiol. MATERIAL AND METHODS. The animals (35 rats) were divided into 5 groups. One group (Cgroup, n=7) was a control, one group (DOXgroup, n=7) received DOX (7.5 mg/kg, i.p.), one group (Mgroup, n=7) was pretreated with melatonin (1mg/kg, i.v.), one group (Ggroup, n=7) was pretreated with glycine (50 mg/kg, i.v.), one group (Ugroup, n=7) was pretreated with unithiol (5 mg/kg, i.v.).The rats were decapitated within 24 hours. The content of glutathione (GSH), glutathione reductase, NAD(P)H:quinone oxidoreductase, glutathioneStransferase and protein carbonyl group in the homogenate of renal mass were detected. RESULTS. Less concentration of GSH was detected in the renal tissue in the DOXgroup as compared with the Cgroup of rats. There were lower levels of GSH in DOXgroup as compared with Mgroup. Activity of glutathione reductase was lower in the DOXgroup than in the Cgroup. There was no difference in the content of protein carbonyl groups. Pretreatment with melatonin and glycin resulted in normalization of GSH levels. CONCLUSION. It was shown that pretreatment with melatonin and glycin reduced the DOX induced renal damage in rats by means of restoration of GSH in the renal tissue.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глицин</kwd><kwd>глютатион</kwd><kwd>доксорубицин</kwd><kwd>оксидативный стресс</kwd><kwd>мелатонин</kwd><kwd>унитиол</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glycin</kwd><kwd>glutathione</kwd><kwd>doxorubicin</kwd><kwd>oxidative stress</kwd><kwd>melatonin</kwd><kwd>unithiol</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование поддержано грантом «Университеты России».  Грант УР 11.01.029</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sessa C. Anticancer agents. In: Cavalli F, Hansen HH, Kaye SB et al, eds. Textbook of Medical Oncology. Martin Dunitz, London, 1997;464489</mixed-citation><mixed-citation xml:lang="en">Sessa C. Anticancer agents. In: Cavalli F, Hansen HH, Kaye SB et al, eds. Textbook of Medical Oncology. Martin Dunitz, London, 1997;464489</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Skladanowski A, Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumor cells. Biochem Pharmacol 1993;46:375382</mixed-citation><mixed-citation xml:lang="en">Skladanowski A, Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumor cells. Biochem Pharmacol 1993;46:375382</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Arola OJ, Saraste A, Pulkki K. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 2000;60:17891792</mixed-citation><mixed-citation xml:lang="en">Arola OJ, Saraste A, Pulkki K. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 2000;60:17891792</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mazue G, Iatropoulos M, Imondi A et al. Anthracyclines: a review of general and special toxicity studies. Int J Oncol 1995;7:713726</mixed-citation><mixed-citation xml:lang="en">Mazue G, Iatropoulos M, Imondi A et al. Anthracyclines: a review of general and special toxicity studies. Int J Oncol 1995;7:713726</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Davies KJ, Doroshow JH. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 1986;261:30603067</mixed-citation><mixed-citation xml:lang="en">Davies KJ, Doroshow JH. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 1986;261:30603067</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Minotti G, Cairo G, Monti E. Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J 1999;13:199 212</mixed-citation><mixed-citation xml:lang="en">Minotti G, Cairo G, Monti E. Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J 1999;13:199 212</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Schafer QF, Buettiner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/ glutathione couple. Free Rad Biol Med 2001;30:11911212</mixed-citation><mixed-citation xml:lang="en">Schafer QF, Buettiner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/ glutathione couple. Free Rad Biol Med 2001;30:11911212</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X, Chen Z, Chua CC et al. Melatonin as an effective protector against doxorubicininduced cardiotoxicity. Am J Physiol Heart Circ Physiol 2002;283:H254H263</mixed-citation><mixed-citation xml:lang="en">Liu X, Chen Z, Chua CC et al. Melatonin as an effective protector against doxorubicininduced cardiotoxicity. Am J Physiol Heart Circ Physiol 2002;283:H254H263</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dziegiel P, Suder E, Surowiak P et al. Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. J Pineal Res 2002;33:95100</mixed-citation><mixed-citation xml:lang="en">Dziegiel P, Suder E, Surowiak P et al. Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. J Pineal Res 2002;33:95100</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Senthilkumar R, Sengottuvelan M, Nalini N. Protective effect of glycine supplementation on the levels of lipid peroxidation and antioxidant enzymes in the erythrocyte of rats with alcoholinduced liver injury. Cell Biochem Funct 2004;22:123128</mixed-citation><mixed-citation xml:lang="en">Senthilkumar R, Sengottuvelan M, Nalini N. Protective effect of glycine supplementation on the levels of lipid peroxidation and antioxidant enzymes in the erythrocyte of rats with alcoholinduced liver injury. Cell Biochem Funct 2004;22:123128</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Shaikh ZA, Tang W. Protection against chronic cadmium toxicity by glycine. Toxicology 1999;132:139146</mixed-citation><mixed-citation xml:lang="en">Shaikh ZA, Tang W. Protection against chronic cadmium toxicity by glycine. Toxicology 1999;132:139146</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Сабирова РА, Иноятова ФХ, Гаппаров ОС. Влияние SHсоединений на особенности изменения активности фер ментов антиоксидантной защиты в различных тканях при остром панкреатите. Эксп Клин Фармакология 2000;3:3335</mixed-citation><mixed-citation xml:lang="en">Сабирова РА, Иноятова ФХ, Гаппаров ОС. Влияние SHсоединений на особенности изменения активности фер ментов антиоксидантной защиты в различных тканях при остром панкреатите. Эксп Клин Фармакология 2000;3:3335</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Habig WG, Pabst MJ, Jakoby WB. Glutathione S transferase. The first enzymic step in mercapturic acid formation. J Biol Chem 1974;249:71307139</mixed-citation><mixed-citation xml:lang="en">Habig WG, Pabst MJ, Jakoby WB. Glutathione S transferase. The first enzymic step in mercapturic acid formation. J Biol Chem 1974;249:71307139</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fisher GR, Gutierrez PL. Free radical formation and DNA strand breakage during metabolism of diaziquone by NAD(P)H quinineacceptor oxidoreductase (DTdiaphorase) and NADPHcytochrome c reductase. Free Radic Biol Med 1991;10:359–370</mixed-citation><mixed-citation xml:lang="en">Fisher GR, Gutierrez PL. Free radical formation and DNA strand breakage during metabolism of diaziquone by NAD(P)H quinineacceptor oxidoreductase (DTdiaphorase) and NADPHcytochrome c reductase. Free Radic Biol Med 1991;10:359–370</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glytathione reductase from rat liver. J Biol Chem 1975;250:54755480</mixed-citation><mixed-citation xml:lang="en">Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glytathione reductase from rat liver. J Biol Chem 1975;250:54755480</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Levin RL, Garland D, Oliver CN. et al. Determination carbonyl content in oxidatively modified proteins. Methods Enzym 1990;186:464478</mixed-citation><mixed-citation xml:lang="en">Levin RL, Garland D, Oliver CN. et al. Determination carbonyl content in oxidatively modified proteins. Methods Enzym 1990;186:464478</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1972;82:7077</mixed-citation><mixed-citation xml:lang="en">Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1972;82:7077</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Annal Biochem1976;72:248 254</mixed-citation><mixed-citation xml:lang="en">Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Annal Biochem1976;72:248 254</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Herman EH, Ferrans VJ, Sanchez JA. Methods of reducing the cardiotoxicity of anthracyclines. In: Muggia FM, Green MD, Speyer JL., eds. Cancer Treatment and the Heart. The Johns Hopkins University, Baltimore,1992:115–169.</mixed-citation><mixed-citation xml:lang="en">Herman EH, Ferrans VJ, Sanchez JA. Methods of reducing the cardiotoxicity of anthracyclines. In: Muggia FM, Green MD, Speyer JL., eds. Cancer Treatment and the Heart. The Johns Hopkins University, Baltimore,1992:115–169.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Basser RL, Green MD. Strategies for prevention of anthracycline cardiotoxicity. Cancer Treat Rev 1993;19:57–77</mixed-citation><mixed-citation xml:lang="en">Basser RL, Green MD. Strategies for prevention of anthracycline cardiotoxicity. Cancer Treat Rev 1993;19:57–77</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sun X, Zhou Z, Kang JY. Attenuation of doxorubicin toxicity in metallothioneinoverexpressing transgenic mouse heart. Cancer Res 2001;61:33823387</mixed-citation><mixed-citation xml:lang="en">Sun X, Zhou Z, Kang JY. Attenuation of doxorubicin toxicity in metallothioneinoverexpressing transgenic mouse heart. Cancer Res 2001;61:33823387</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Minotti G. Sources and role of iron in lipid peroxidation. Chem Res Toxicol 1993;6:134146</mixed-citation><mixed-citation xml:lang="en">Minotti G. Sources and role of iron in lipid peroxidation. Chem Res Toxicol 1993;6:134146</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Powis G. Free radical formation by antitumor quinones. Free Rad Biol Med 1989;6:63101</mixed-citation><mixed-citation xml:lang="en">Powis G. Free radical formation by antitumor quinones. Free Rad Biol Med 1989;6:63101</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Thornalley PJ, Dodd NJ. Free radical production from normal and adriamycintreated rat cardiac sarcosomes. Biochem Pharmacol 1985;34:669–674</mixed-citation><mixed-citation xml:lang="en">Thornalley PJ, Dodd NJ. Free radical production from normal and adriamycintreated rat cardiac sarcosomes. Biochem Pharmacol 1985;34:669–674</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Klatt P, Lamas S. Regulation of protein function by S glutathiolation in response to oxidative stress. Eur J Biochem 2000;267:49284944</mixed-citation><mixed-citation xml:lang="en">Klatt P, Lamas S. Regulation of protein function by S glutathiolation in response to oxidative stress. Eur J Biochem 2000;267:49284944</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001;15:2922—2933</mixed-citation><mixed-citation xml:lang="en">Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001;15:2922—2933</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Reiter RJ. Melatonin: Lowering the high price of free radicals. News Physiol Sci 2000;15:246250</mixed-citation><mixed-citation xml:lang="en">Reiter RJ. Melatonin: Lowering the high price of free radicals. News Physiol Sci 2000;15:246250</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Okatani Y, Wakatsuki A, Kaneda C. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 2000;28:8996</mixed-citation><mixed-citation xml:lang="en">Okatani Y, Wakatsuki A, Kaneda C. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 2000;28:8996</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Anusevicius Z, Sarlauscas J, Cenas N. Twoelectron reduction of quinones by rat liver NAD(P)H:quinone oxidoreductase: quantitative structureactivity relationships. Arch Biochem Biophys 2002;404:254256</mixed-citation><mixed-citation xml:lang="en">Anusevicius Z, Sarlauscas J, Cenas N. Twoelectron reduction of quinones by rat liver NAD(P)H:quinone oxidoreductase: quantitative structureactivity relationships. Arch Biochem Biophys 2002;404:254256</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Beyer RE, SeguraAquilar J, Di Bernardo S et al. The role of DTdiaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc Natl Acad Sci USA 1996;93:25282532</mixed-citation><mixed-citation xml:lang="en">Beyer RE, SeguraAquilar J, Di Bernardo S et al. The role of DTdiaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc Natl Acad Sci USA 1996;93:25282532</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Siegel D, Gustafson DL, Dehn DL et al. NAD(P)H:Quinone Oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004;65:12381247</mixed-citation><mixed-citation xml:lang="en">Siegel D, Gustafson DL, Dehn DL et al. NAD(P)H:Quinone Oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004;65:12381247</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Radjendirane V, Joseph P, Lee YH et al. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 1998;273:73827389</mixed-citation><mixed-citation xml:lang="en">Radjendirane V, Joseph P, Lee YH et al. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 1998;273:73827389</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Nguen T, Sherratt PJ, Pickett C. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003;43:233 260.</mixed-citation><mixed-citation xml:lang="en">Nguen T, Sherratt PJ, Pickett C. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003;43:233 260.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
